Literature DB >> 6305543

Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.

W N Bartholomaeus, G R Shellam, J E Allan, W D Reed, R A Joske.   

Abstract

Autoantibodies to liver specific lipoprotein (LSP) are produced following acute non-fatal hepatitis in murine cytomegalovirus (MCMV) infected mice. Both C57B1 and BALB/c mice produced a transient LSP autoantibody response demonstrated by passive haemagglutination and enzyme linked immunosorbent assay. C57Bl mice produced both IgM and IgG LSP autoantibody and BALB/c mice produced only IgM autoantibody. The autoantibody was species non-specific, reacting with both mouse and rabbit LSP. Plasma containing LSP autoantibody reacted with the surface of normal mouse hepatocytes by immunofluorescence. This model provides an opportunity for study of LSP autoantibody production during viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305543      PMCID: PMC1535580     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection.

Authors:  P Andersen; H K Andersen
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

3.  Cytomegalovirus-induced immune suppression. I. Humoral immunity.

Authors:  R J Howard; J S Najarian
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

4.  Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity.

Authors:  R J Howard; J Miller; J S Najarian
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

5.  Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis.

Authors:  O Wager; J A Räsänen; A Hagman; E Klemola
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

6.  Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations.

Authors:  D Henson; R D Smith; J Gehrke
Journal:  Am J Pathol       Date:  1966-11       Impact factor: 4.307

7.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

8.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

9.  Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse.

Authors:  J E Chalmer; J S Mackenzie; N F Stanley
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

10.  Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection.

Authors:  L B Olding; D T Kingsbury; M B Oldstone
Journal:  J Gen Virol       Date:  1976-11       Impact factor: 3.891

View more
  11 in total

Review 1.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 3.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

Review 4.  Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Authors:  Muhammed Yüksel; Debby Laukens; Femke Heindryckx; Hans Van Vlierberghe; Anja Geerts; F Susan Wong; Li Wen; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2014-08-12       Impact factor: 1.925

5.  Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.

Authors:  W N Bartholomaeus; H O'Donoghue; D Foti; C M Lawson; G R Shellam; W D Reed
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

6.  Thymus-dependence of autoantibody responses to liver specific lipoprotein in the mouse.

Authors:  W N Bartholomaeus; H O'Donoghue; W D Reed
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Studies on the pathogenesis of murine experimental autoimmune active hepatitis: sensitized T cell involvement in its induction.

Authors:  K Araki; H Yamamoto; S Fujimoto
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

8.  Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice.

Authors:  J E Allan; G R Shellam
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

9.  A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo.

Authors:  A J Chapman; H E Farrell; J A Thomas; J M Papadimitriou; M J Garlepp; A A Scalzo; G R Shellam
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  Autoantibody to liver-specific lipoprotein in the mouse: regulation by naturally occurring autoantigen specific suppressor cells.

Authors:  W N Bartholomaeus; W D Reed; R A Joske
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.